R&G PharmaStudies Co., Ltd. (SHE:301333)
China
· Delayed Price · Currency is CNY 63.47
-2.36 (-3.58%)
At close: Apr 29, 2026
R&G PharmaStudies Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Cash & Equivalents | 1,144 | 1,128 | 1,069 | 991.48 | 1,522 | 361.6 | Upgrade
|
| Trading Asset Securities | 574.9 | 620.12 | 707.61 | 712.39 | - | - | Upgrade
|
| Cash & Short-Term Investments | 1,719 | 1,748 | 1,776 | 1,704 | 1,522 | 361.6 | Upgrade
|
| Cash Growth | 0.68% | -1.61% | 4.25% | 11.93% | 321.00% | 23.07% | Upgrade
|
| Accounts Receivable | 372.85 | 337.36 | 279.37 | 238.31 | 222.26 | 179.76 | Upgrade
|
| Other Receivables | 2.32 | 8.75 | 7.52 | 7.67 | 7.29 | 8.78 | Upgrade
|
| Receivables | 375.17 | 346.11 | 286.89 | 245.98 | 229.55 | 188.54 | Upgrade
|
| Inventory | 55.8 | 59.02 | 65.23 | 51.26 | 53.01 | 43.27 | Upgrade
|
| Other Current Assets | 11.78 | 2.48 | 3.39 | 5.1 | 3.75 | 11.71 | Upgrade
|
| Total Current Assets | 2,162 | 2,155 | 2,132 | 2,006 | 1,809 | 605.11 | Upgrade
|
| Property, Plant & Equipment | 47.17 | 51.37 | 55.58 | 40.93 | 52.45 | 33.75 | Upgrade
|
| Long-Term Investments | 79.26 | 79.49 | 32.78 | - | - | - | Upgrade
|
| Goodwill | 85.6 | 85.6 | 85.6 | 0.08 | 0.08 | 0.08 | Upgrade
|
| Other Intangible Assets | 15.35 | 16.25 | 19.43 | 17.93 | 12.83 | 17.88 | Upgrade
|
| Long-Term Deferred Tax Assets | 10.95 | 9.96 | 8.61 | 7.62 | 7.28 | 4.16 | Upgrade
|
| Long-Term Deferred Charges | 1.38 | 1.68 | 2.4 | 1.04 | 1.83 | 2.51 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | - | 13.98 | Upgrade
|
| Total Assets | 2,401 | 2,400 | 2,336 | 2,074 | 1,883 | 677.47 | Upgrade
|
| Accounts Payable | 45.07 | 46.17 | 50.97 | 40.87 | 32.2 | - | Upgrade
|
| Accrued Expenses | 38.4 | 37.52 | 34.06 | 32.14 | 32.89 | 49.36 | Upgrade
|
| Short-Term Debt | - | - | 55.14 | - | - | - | Upgrade
|
| Current Portion of Leases | - | 10.14 | 8.91 | 5.99 | 9.55 | 7.08 | Upgrade
|
| Current Income Taxes Payable | 10.78 | 7.81 | 6.91 | 7.17 | 4.08 | 2.86 | Upgrade
|
| Current Unearned Revenue | 199.6 | 223.25 | 235.12 | 200.42 | 183.22 | 150.9 | Upgrade
|
| Other Current Liabilities | 30.16 | 60.18 | 45.39 | 27.78 | 18.57 | 24.24 | Upgrade
|
| Total Current Liabilities | 359.47 | 385.07 | 436.49 | 314.36 | 280.52 | 234.43 | Upgrade
|
| Long-Term Leases | 7.04 | 7.73 | 7.81 | 2.88 | 6.13 | 3.9 | Upgrade
|
| Long-Term Unearned Revenue | 1.6 | 1.6 | 0.71 | - | - | 1 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.28 | 3.73 | 4.25 | 1.76 | 2.42 | 0.05 | Upgrade
|
| Other Long-Term Liabilities | 26.16 | 25.75 | 50.83 | 0.16 | 0.27 | 0.28 | Upgrade
|
| Total Liabilities | 397.56 | 423.89 | 500.09 | 319.17 | 289.35 | 239.66 | Upgrade
|
| Common Stock | 96.58 | 96.58 | 96.58 | 96 | 60 | 45 | Upgrade
|
| Additional Paid-In Capital | 1,062 | 1,056 | 1,057 | 1,057 | 1,079 | 17.71 | Upgrade
|
| Retained Earnings | 861.5 | 838.67 | 717.07 | 596.05 | 448.52 | 359.71 | Upgrade
|
| Treasury Stock | -22.95 | -22.95 | -37.96 | - | - | - | Upgrade
|
| Comprehensive Income & Other | -0.59 | -0.61 | -0.08 | -0.41 | -0.15 | 0.12 | Upgrade
|
| Total Common Equity | 1,996 | 1,968 | 1,833 | 1,748 | 1,588 | 422.53 | Upgrade
|
| Minority Interest | 7.63 | 7.56 | 3.62 | 6.24 | 5.97 | 15.28 | Upgrade
|
| Shareholders' Equity | 2,004 | 1,976 | 1,836 | 1,755 | 1,594 | 437.81 | Upgrade
|
| Total Liabilities & Equity | 2,401 | 2,400 | 2,336 | 2,074 | 1,883 | 677.47 | Upgrade
|
| Total Debt | 42.5 | 17.87 | 71.86 | 8.86 | 15.68 | 10.98 | Upgrade
|
| Net Cash (Debt) | 1,676 | 1,730 | 1,704 | 1,695 | 1,507 | 350.62 | Upgrade
|
| Net Cash Growth | -1.43% | 1.49% | 0.56% | 12.50% | 329.70% | 19.33% | Upgrade
|
| Net Cash Per Share | 17.58 | 18.07 | 17.87 | 17.66 | 18.33 | 4.88 | Upgrade
|
| Filing Date Shares Outstanding | 95.11 | 95.99 | 95.14 | 96 | 96 | 72 | Upgrade
|
| Total Common Shares Outstanding | 95.11 | 95.99 | 95.14 | 96 | 96 | 72 | Upgrade
|
| Working Capital | 1,802 | 1,770 | 1,695 | 1,692 | 1,528 | 370.68 | Upgrade
|
| Book Value Per Share | 20.99 | 20.50 | 19.26 | 18.21 | 16.54 | 5.87 | Upgrade
|
| Tangible Book Value | 1,895 | 1,866 | 1,727 | 1,730 | 1,575 | 404.56 | Upgrade
|
| Tangible Book Value Per Share | 19.93 | 19.44 | 18.16 | 18.02 | 16.40 | 5.62 | Upgrade
|
| Buildings | - | 14.43 | 14.43 | 14.43 | 14.43 | - | Upgrade
|
| Machinery | - | 80.38 | 78.02 | 57.08 | 56.03 | 51.4 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.